JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varma, D. R.
Right arrow Articles by Benfey, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varma, D. R.
Right arrow Articles by Benfey, B. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHLORAZINE
*CHLORPROMAZINE
*GUANETHIDINE
*METHYLDOPA
*RESERPINE
*TYRAMINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 141, Issue 3, 310-313, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


ANTAGONISM OF RESERPINE-INDUCED SUBSENSITIVITY TO TYRAMINE BY METHYLDOPA

D. R. Varma 1 and B. G. Benfey 1

1 Department of Pharmacology, McGill University, Montreal, Canada

The cardiovascular actions of tyramine in spinal cats and its inotropic action on the cat isolated papillary muscle were tested following methyldopa, reserpine, and reserpine injected after methyldopa. It was found that reserpine reduced the pressor and inotropic effects of tyramine and stellate ganglion stimulation in spinal cats and the inotropic actions of tyramine and butyrylcholine on the papillary muscle, whereas methyldopa did not inhibit these responses. However, in cats pretreated with methyldopa, reserpine did not reduce the actions of tyramine.

As the effects of stellate ganglion stimulation and butyrylcholine were inhibited when reserpine had been injected after methyldopa, it is concluded that methyldopa did not interfere with the release of endogenous catecholamine by reserpine. On the basis of these results, the cause of the subsensitivity to tyramine following reserpine is suggested to be an antagonism between reserpine and tyramine at the receptor level.

Submitted on May 6, 1963
Accepted on May 22, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.